The probiotics sector is in the spotlight as consumer demand surges and attention to quality and standards among a range of stakeholders—including critics—is piqued. As companies seek innovative ways to deliver, it is critical they stay updated on scientific and regulatory developments shaping the dynamic probiotics marketplace. Join CRN and Natural Products INSIDER January 22 from 2–4 pm Eastern for a webinar that will get you up to speed on the current state of probiotics—and what’s to come—across a range of disciplines.
Moderated by CRN’s Gisele Atkinson, vice president, Quality & Technical Affairs
CEO/Founder, BioForm Solutions
Applying over 25 years of flow cytometry experience in cancer and autoimmune research to developing new assays to microbial analysis, leveraging expertise in multicolor flow cytometry and cell sorting for the probiotic industry. Dana worked as a senior scientist for CancerVax, Arena Pharmaceuticals, and Pfizer before forming nanoBioforms in 2014 which became BioForm Solutions in 2016. Dana earned two B.S. degrees, one in BioChemistry and the other in Molecular, Cellular and Developmental Biology at the University of Colorado. Dana is a member of the Southern California Flow Cytometry Association and has served on the program committee for the annual summit since 2016.
James C. Griffiths, Ph.D.
Senior Vice President, International & Scientific Affairs, CRN
Dr. Griffiths is responsible for CRN’s science-based international policy and regulatory work, and is the CRN staff liaison for CRN-International (CRN-I). He has more than 30 years of experience in the area of food safety and regulatory affairs. Prior to joining CRN, he spent five years with the United States Pharmacopoeia (USP) where he managed food and dietary supplement strategic initiatives, including those related to global food and dietary supplement alliances. He began his career as a regulatory review toxicologist at the U.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition. His background also includes various scientific and regulatory positions at Burdock and Associates, the Flavor & Extract Manufacturers’ Association, International Specialty Products, Avon Products, and others. He has published extensively in peer-reviewed publications and has an adjunct faculty appointment at the JSS University System in Mysore, Karnataka, India. Dr. Griffiths holds a B.A. in biology from Columbia Union College in Maryland, earned his Ph.D. in Toxicology from Rutgers University & Robert Wood Johnson Medical School in New Jersey, and completed post-doctoral training at the Heinrich Heine University in Düsseldorf, Germany.
Jeremy Bartos, Ph.D.,
Senior Vice President, Research & Development, MeriCal
Jeremy Bartos, PhD, is the Senior Vice President of Research & Development at MeriCal. He has over 10 years of experience working in the dietary supplements industry in a variety of product development, innovation, business development and sales roles. In his current role, he utilizes his knowledge of the scientific and clinical benefits of nutraceutical ingredients to create new, innovative finished product solutions for the industry, specializing in probiotic, sports nutrition, and health condition-specific products. His accolades include authoring peer-reviewed publications, co-inventing numerous natural products patents and launching both branded proprietary ingredients and successful finished products tailored for various dietary supplement markets. Dr. Bartos was an NCI-funded Post-Doctoral Fellow in the Department of Biochemistry at the University of Rochester School of Medicine and Dentistry, where he focused on the molecular mechanisms of DNA replication. Dr. Bartos received his B.S. in Ecology and Evolutionary Biology from the University of Rochester and his PhD in Molecular Biology from Roswell Park Cancer Institute, a division of the State University of New York at Buffalo.
Steven Dentali, Ph.D.
Industry Consultant, Dentali Botanical Sciences
Steven Dentali, Ph.D., widely considered an international authority on botanical ingredients, heads the industry consulting firm Dentali Botanical Sciences. He recently served as Research Fellow and VP, Botanical Sciences at Herbalife Nutrition after eleven years as Science Officer for the American Herbal Products Association. Dr. Dentali holds a Ph.D. in Pharmaceutical Sciences, with a Natural Products Chemistry specialization, from the University of Arizona, where he was the American Foundation for Pharmaceutical Education Edwin Leigh Newcomb Memorial Fellow.
As a key opinion leader and subject matter expert, Dr. Dentali has focused on product safety, ingredient integrity, and claims substantiation, guiding the establishment of shared botanical standards with governmental and educational standard-setting organizations including the American Botanical Council, the American Herbal Pharmacopoeia, AOAC INTERNATIONAL where he was named as a 2018 Fellow, the International Aloe Science Council, the Canadian government, the US National Institutes of Health, NSF/ANSI, and the U.S. Pharmacopeial Convention.
Virginia (Kit) Streusand Goldman, Ph.D.
Director, Dietary Supplements and Herbal Medicines, United States Pharmacopeia
Kit S. Goldman, Ph.D. is responsible for the team that develops documentary standards for dietary supplements, including botanicals, herbal medicines, vitamins and minerals, oils, small molecules, probiotics and proteins at the US Pharmacopeia. Prior to USP, she worked in developing, launching and providing technical support (e.g., microbiological quality testing; basic microbiological research) for such brands as Neosporin®, BENGAY® and Purell®. She has also developed and supported Class I and Class II medical devices, and led manufacturing and supply chain operations.
Kit received her Ph.D. from The University of Michigan, and conducted post-doctoral research at the University of Illinois.
Joshua Baisley, H.B.Sc.
Vice President, Clinical Design & Delivery, Nutrasource Pharmaceutical & Nutraceutical Services
Joshua Baisley is the Vice-President Clinical Design & Delivery of Nutrasource Pharmaceutical & Nutraceutical Services, a leading contract research organization that helps companies bring products to market with strong science and regulatory confidence – from concept to claim. Before devoting his work full-time to Nutrasource, Mr. Baisley participated on Health Canada’s Vigilance Expert Working Group representing the dietary supplement industry to work on harmonization of safety reporting for supplements, drugs and biologics. With over 20 years health products industry experience in quality assurance, clinical, preclinical & regulatory affairs, Joshua has been an active member of the probiotic community serving on the International Probiotics Association (IPA) Board of Directors, co-chairing the IPA Technology & Standards Committee, publishing articles as well as presenting at various industry workshops and events.